Nitric oxide synthase modulates CFA-induced thermal hyperalgesia through cytokine regulation in mice

Molecular Pain

Volumn 6, Issue , 2010, Pages

  Chen, Yong ^a   Boettger, Michael K ^a   Reif, Andreas ^a   Schmitt, Angelika ^a   Üçeyler, Nurcan ^a   Sommer, Claudia ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

7 NITROINDAZOLE; AMINOGUANIDINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FREUND ADJUVANT; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 1BETA; N(G) NITROARGININE METHYL ESTER; N5 (1 IMINOETHYL)ORNITHINE; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; CYTOKINE; ENZYME INHIBITOR; ISOENZYME; MESSENGER RNA; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NOS1 PROTEIN, MOUSE; NOS2 PROTEIN, MOUSE; NOS3 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME INHIBITION; GENE EXPRESSION; HYPERALGESIA; MALE; MOUSE; NONHUMAN; PAIN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; NOCICEPTIVE RECEPTOR; PATHOPHYSIOLOGY; SENSORY RECEPTOR;

ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; FREUND'S ADJUVANT; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HYPERALGESIA; INFLAMMATION MEDIATORS; INTERLEUKIN-10; INTERLEUKIN-1BETA; ISOENZYMES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; NOCICEPTORS; RNA, MESSENGER; SENSORY RECEPTOR CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77950422605     PISSN: 17448069     EISSN: None     Source Type: Journal    
DOI: 10.1186/1744-8069-6-13     Document Type: Article

References (63)

1. Guzik TJ, Korbut R, Adamek-Guzik T. Nitric oxide and superoxide in inflammation and immune regulation. J Physiol Pharmacol 2003, 54:469-487.
2. Laroux FS, Lefer DJ, Kawachi S, Scalia R, Cockrell AS, Gray L, Van der Heyde H, Hoffman JM, Grisham MB. Role of nitric oxide in the regulation of acute and chronic inflammation. Antioxid Redox Signal 2000, 2:391-396. 10.1089/15230860050192161, 11229352.
3. Aley KO, McCarter G, Levine JD. Nitric oxide signaling in pain and nociceptor sensitization in the rat. J Neurosci 1998, 18:7008-7014.
4. Luo ZD, Cizkova D. The role of nitric oxide in nociception. Curr Rev Pain 2000, 4:459-466.
5. Malmberg AB, Yaksh TL. Spinal nitric oxide synthesis inhibition blocks NMDA-induced thermal hyperalgesia and produces antinociception in the formalin test in rats. Pain 1993, 54:291-300. 10.1016/0304-3959(93)90028-N, 8233543.
6. Meller ST, Gebhart GF. Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain 1993, 52:127-136. 10.1016/0304-3959(93)90124-8, 8455960.
7. Forstermann U, Gath I, Schwarz P, Closs EI, Kleinert H. Isoforms of nitric oxide synthase: properties, cellular distribution and expressional control. Biochem Pharmacol 1995, 50:1321-1332. 10.1016/0006-2952(95)00181-6, 7503779.
8. Mayer B. Biochemistry and molecular pharmacology of nitric oxide synthase. Nitric oxide in the nervous system 1995, 21-42. New York, Academic Press, Vincent SR.
9. Paakkari I, Lindsberg P. Nitric oxide in the central nervous system. Ann Med 1995, 27:369-377. 10.3109/07853899509002590, 7546627.
10. Chu YC, Guan Y, Skinner J, Raja SN, Johns RA, Tao YX. Effect of genetic knockout or pharmacologic inhibition of neuronal nitric oxide synthase on complete Freund's adjuvant-induced persistent pain. Pain 2005, 119:113-123. 10.1016/j.pain.2005.09.024, 16297560.
11. Osborne MG, Coderre TJ. Effects of intrathecal administration of nitric oxide synthase inhibitors on carrageenan-induced thermal hyperalgesia. Br J Pharmacol 1999, 126:B1840-1846.
12. Semos ML, Headley PM. The role of nitric oxide in spinal nociceptive reflexes in rats with neurogenic and non-neurogenic peripheral inflammation. Neuropharmacology 1994, 33:1487-1497. 10.1016/0028-3908(94)90053-1, 7532833.
13. De Alba J, Clayton NM, Collins SD, Colthup P, Chessell I, Knowles RG. GW27 a novel and highly selective inhibitor of the inducible isoform of nitric oxide synthase (iNOS), shows analgesic effects in rat models of inflammatory and neuropathic pain. Pain 4150, 120:170-181.
14. Handy RL, Moore PK. Effects of selective inhibitors of neuronal nitric oxide synthase on carrageenan-induced mechanical and thermal hyperalgesia. Neuropharmacology 1998, 37:37-43. 10.1016/S0028-3908(97)00201-3, 9680257.
15. LaBuda CJ, Koblish M, Tuthill P, Dolle RE, Little PJ. Antinociceptive activity of the selective iNOS inhibitor AR-C102222 in rodent models of inflammatory, neuropathic and post-operative pain. Eur J Pain 2006, 10:505-512. 10.1016/j.ejpain.2005.07.004, 16125426.
16. Tang Q, Svensson CI, Fitzsimmons B, Webb M, Yaksh TL, Hua XY. Inhibition of spinal constitutive NOS-2 by 1400W attenuates tissue injury and inflammation-induced hyperalgesia and spinal p38 activation. Eur J Neurosci 2007, 25:2964-2972. 10.1111/j.1460-9568.2007.05576.x, 17561811.
17. Tao F, Tao YX, Mao P, Zhao C, Li D, Liaw WJ, Raja SN, Johns RA. Intact carrageenan-induced thermal hyperalgesia in mice lacking inducible nitric oxide synthase. Neuroscience 2003, 120:847-854. 10.1016/S0306-4522(03)00362-2, 12895524.
18. Tao F, Tao YX, Zhao C, Doré S, Liaw WJ, Raja SN, Johns RA. Differential roles of neuronal and endothelial nitric oxide synthases during carrageenan-induced inflammatory hyperalgesia. Neuroscience 2004, 128:421-430. 10.1016/j.neuroscience.2004.06.038, 15350652.
19. Kidd BL, Urban LA. Mechanisms of inflammatory pain. Br J Anaesth 2001, 87:3-11. 10.1093/bja/87.1.3, 11460811.
20. Ji RR, Woolf CJ. Neuronal plasticity and signal transduction in nociceptive neurons: implications for the initiation and maintenance of pathological pain. Neurobiol Dis 2001, 8:1-10. 10.1006/nbdi.2000.0360, 11162235.
21. Neumann S, Doubell TP, Leslie T, Woolf CJ. Inflammatory pain hypersensitivity mediated by phenotypic switch in myelinated primary sensory neurons. Nature 1996, 384:360-364. 10.1038/384360a0, 8934522.
22. Cunha F, Poole S, Lorenzetti B, Ferreira S. The pivotal role of tumor necrosis factor alpha in the development of inflammatory hyperalgesia. Br J Pharmacol 1992, 107:660-664. 1907751, 1472964.
23. Ferreira S, Lorenzetti B, Bristow A, Poole S. Interleukin-1β as a potent hyperalgesic agent antagonized by a tripeptide analogue. Nature 1988, 334:698-700. 10.1038/334698a0, 3137474.
24. Verri WA, Cunha TM, Parada CA, Poole S, Cunha FQ, Ferreira SH. Hypernociceptive role of cytokines and chemokines: targets for analgesic drug development?. Pharmacol Ther 2006, 112:116-138. 10.1016/j.pharmthera.2006.04.001, 16730375.
25. Poole S, Cunha FQ, Ferreira SH. Hyperalgesia from subcutaneous cytokines. Cytokines and Pain 1999, 59-87. Basel, Birkhäuser, Watkins LR, Maier SF.
26. Üçeyler N, Sommer C. Cytokine-induced pain: basic science and clinical implications. Rev Analg 2007, 9:87-103.
27. Üçeyler N, Sommer C. Cytokine regulation in animal models of neuropathic pain and in human diseases. Neurosci Lett 2008, 437:194-198. 10.1016/j.neulet.2008.03.050, 18403115.
28. Ferreira SH. Inflammatory pain: the role of cytokines and its control by drugs which release nitric oxide. Ann Ist Super Sanita 1993, 29:367-373.
29. Hartrick CT. Increased production of nitric oxide stimulated by interferon-gamma from peripheral blood monocytes in patients with complex regional pain syndrome. Neurosci Lett 2002, 323:75-77. 10.1016/S0304-3940(02)00112-X, 11911993.
30. Meller ST, Dykstra C, Grzybycki D, Murphy S, Gebhart GF. The possible role of glia in nociceptive processing and hyperalgesia in the spinal cord of the rat. Neuropharmacology 1994, 33:1471-1478. 10.1016/0028-3908(94)90051-5, 7532831.
31. Plunkett JA, Yu CG, Easton JM, Bethea JR, Yezierski RP. Effects of interleukin-10 (IL-10) on pain behavior and gene expression following excitotoxic spinal cord injury in the rat. Exp Neurol 2001, 168:144-154. 10.1006/exnr.2000.7604, 11170729.
32. Sung CS, Wen ZH, Chang WK, Chan KH, Ho ST, Tsai SK, Chang YC, Wong CS. Inhibition of p38 mitogen-activated protein kinase attenuates interleukin-1beta-induced thermal hyperalgesia and inducible nitric oxide synthase expression in the spinal cord. J Neurochem 2005, 94:742-752. 10.1111/j.1471-4159.2005.03226.x, 16033422.
33. Sung CS, Wen ZH, Chang WK, Ho ST, Tsai SK, Chang YC, Wong CS. Intrathecal interleukin-1beta administration induces thermal hyperalgesia by activating inducible nitric oxide synthase expression in the rat spinal cord. Brain Res 2004, 1015:145-153. 10.1016/j.brainres.2004.04.068, 15223378.
34. Xu XJ, Hao JX, Olsson T, Kristensson K, van der Meide PH, Wiesenfeld-Hallin Z. Intrathecal interferon-gamma facilitates the spinal nociceptive flexor reflex in the rat. Neurosci Lett 1994, 182:263-266. 10.1016/0304-3940(94)90812-5, 7715823.
35. Holguin A, O'Connor KA, Biedenkapp J, Campisi J, Wieseler-Frank J, Milligan ED, Hansen MK, Spataro L, Maksimova E, Bravmann C, Martin D, Fleshner M, Maier SF, Watkins LR. HIV-1 gp120 stimulates proinflammatory cytokine-mediated pain facilitation via activation of nitric oxide synthase-I (nNOS). Pain 2004, 110:517-530. 10.1016/j.pain.2004.02.018, 15288392.
36. Laubach VE, Shesely EG, Smithies O, Sherman PA. Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc Natl Acad Sci USA 1995, 92:10688-10692. 10.1073/pnas.92.23.10688, 40677, 7479866.
37. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, Fishman MC. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 1995, 377:239-242. 10.1038/377239a0, 7545787.
38. Huang PL, Dawson TM, Bredt DS, Snyder SH, Fishman MC. Targeted disruption of the neuronal nitric oxide synthase gene. Cell 1993, 75:1273-1286. 10.1016/0092-8674(93)90615-W, 7505721.
39. Hargreaves K, Dubner R, Brown F, Flores C, Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988, 32:77-88. 10.1016/0304-3959(88)90026-7, 3340425.
40. Chen Y, Sommer C. Activation of the nociceptin opioid system in rat sensory neurons produces antinociceptive effects in inflammatory pain: involvement of inflammatory mediators. J Neurosci Res 2007, 85:1478-1488. 10.1002/jnr.21272, 17387690.
41. Kleinschnitz C, Brinkhoff J, Zelenka M, Sommer C, Stoll G. The extent of cytokine induction in peripheral nerve lesions depends on the mode of injury and NMDA receptor signaling. J Neuroimmunol 2004, 149:77-83. 10.1016/j.jneuroim.2003.12.013, 15020067.
42. Kleinschnitz C, Hofstetter HH, Meuth SG, Bräuninger S, Sommer C, Stoll G. cell infiltration after chronic constriction injury of mouse sciatic nerve is associated with interleukin-17 expression. Exp Neurol 2006, 200:T480-485.
43. Handy RL. Nitric oxide and inflammatory pain. Pain and Neurogenic Inflammation 1999, 81-102. Basel, Birkhäuser, Brain SD, Moore PK.
44. Wu J, Fang L, Lin Q, Willis WD. Nitric oxide synthase in spinal cord central sensitization following intradermal injection of capsaicin. Pain 2001, 94:47-58. 10.1016/S0304-3959(01)00340-2, 11576744.
45. Lam HH, Hanley DF, Trapp BD, Saito S, Raja S, Dawson TM, Yamaguchi H. Induction of spinal cord neuronal nitric oxide synthase (NOS) after formalin injection in the rat hind paw. Neurosci Lett 1996, 210:201-204. 10.1016/0304-3940(96)12702-6, 8805130.
46. Poole S, Cunha FQ, Ferreira SH. Bradykinin, cytokines and inflammatory hyperalgesia. Pain and Neuroimmune Interactions 2000, 31-54. New York, Kluwer Academic/Plenum Publishers, Saadé NE, Apkarian AV, Jabbur SJ.
47. Safieh-Garabedian B, Poole S, Allchorne A, Winter J, Woolf CJ. Contribution of interleukin-1 beta to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia. Br J Pharmacol 1995, 115:1265-1275. 1908795, 7582555.
48. Schäfers M, Svensson CI, Sommer C, Sorkin LS. Tumor necrosis factor-alpha induces mechanical allodynia after spinal nerve ligation by activation of p38 MAPK in primary sensory neurons. J Neurosci 2003, 23:2517-2521.
49. Woolf CJ, Allchorne A, Safieh-Garabedian B, Poole S. Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumour necrosis factor alpha. Br J Pharmacol 1997, 121:417-424. 10.1038/sj.bjp.0701148, 1564704, 9179382.
50. Zelenka M, Schäfers M, Sommer C. Intraneural injection of interleukin-1beta and tumor necrosis factor-alpha into rat sciatic nerve at physiological doses induces signs of neuropathic pain. Pain 2005, 116:257-263. 10.1016/j.pain.2005.04.018, 15964142.
51. Karam MC, Hamdan HG, Abi Chedid NA, Bodman-Smith KB, Baroody GM. Interleukin-10 reduces hyperalgesia and the level of Interleukin-1beta in BALB/c mice infected with Leishmania major with no major effect on the level of Interleukin-6. J Neuroimmunol 2007, 183:43-49. 10.1016/j.jneuroim.2006.11.003, 17184847.
52. Ledeboer A, Jekich BM, Sloane EM, Mahoney JH, Langer SJ, Milligan ED, Martin D, Maier SF, Johnson KW, Leinwand LA, Chavez RA, Watkins LR. Intrathecal interleukin-10 gene therapy attenuates paclitaxel-induced mechanical allodynia and proinflammatory cytokine expression in dorsal root ganglia in rats. Brain Behav Immun 2007, 21:686-698. 10.1016/j.bbi.2006.10.012, 2063454, 17174526.
53. Milligan ED, Langer SJ, Sloane EM, He L, Wieseler-Frank J, O'Connor K, Martin D, Forsayeth JR, Maier SF, Johnson K, Chavez RA, Leinwand LA, Watkins LR. Controlling pathological pain by adenovirally driven spinal production of the anti-inflammatory cytokine, interleukin-10. Eur J Neurosci 2005, 21:2136-2148. 10.1111/j.1460-9568.2005.04057.x, 15869510.
54. Wagner R, Janjigian M, Myers RR. Anti-inflammatory interleukin-10 therapy in CCI neuropathy decreases thermal hyperalgesia, macrophage recruitment, and endoneurial TNF-α expression. Pain 1998, 74:35-42. 10.1016/S0304-3959(97)00148-6, 9514558.
55. Buckner CK, Saban R, Castleman WL, Will JA. Analysis of leukotriene receptor antagonists on isolated human intralobar airways. Ann N Y Acad Sci 1988, 524:181-186. 10.1111/j.1749-6632.1988.tb38540.x, 2837953.
56. Furfine ES, Harmon MF, Paith JE, Garvey EP. Selective inhibition of constitutive nitric oxide synthase by L-NG-nitroarginine. Biochemistry 1993, 32:8512-8517. 10.1021/bi00084a017, 7689333.
57. Garvey EP, Tuttle JV, Covington K, Merrill BM, Wood ER, Baylis SA, Charles IG. Purification and characterization of the constitutive nitric oxide synthase from human placenta. Arch Biochem Biophy 1994, 311:235-241.
58. Southan GJ, Szabó C. Selective pharmacological inhibition of distinct nitric oxide synthase isoforms. Biochem Pharmacol 1996, 51:383-394. 10.1016/0006-2952(95)02099-3, 8619882.
59. Gee K, Angel JB, Ma W, Mishra S, Gajanayaka N, Parato K, Kumar A. Intracellular HIV-Tat expression induces IL-10 synthesis by the CREB-1 transcription factor through Ser133 phosphorylation and its regulation by the ERK1/2 MAPK in human monocytic cells. J Biol Chem 2006, 281:31647-31658. 10.1074/jbc.M512109200, 16920714.
60. Jongeneel CV. Transcriptional regulation of the tumor necrosis factor alpha gene. Immunobiology 1995, 193:210-216.
61. Watkins LR, Hansen MK, Nguyen KT, Lee JE, Maier SF. Dynamic regulation of the proinflammatory cytokine, interleukin-1beta: molecular biology for non-molecular biologists. Life Sci 1999, 65:449-481. 10.1016/S0024-3205(99)00095-8, 10462074.
62. Riccio A, Alvania RS, Lonze BE, Ramanan N, Kim T, Huang Y, Dawson TM, Snyder SH, Ginty DD. A nitric oxide signaling pathway controls CREB-mediated gene expression in neurons. Mol Cell 2006, 21:283-294. 10.1016/j.molcel.2005.12.006, 16427017.
63. Boettger MK, Üceyler N, Zelenka M, Schmitt A, Reif A, Chen Y, Sommer C. Differences in inflammatory pain in nNOS-, iNOS- and eNOS-deficient mice. Eur J Pain 2007, 11:810-818. 10.1016/j.ejpain.2006.12.008, 17395508.